XERS
Xeris Pharmaceuticals Inc
NASDAQ: XERS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$6.53
-1.51% today
Updated 2026-05-08
Market cap
$1.14B
P/E ratio
0.00
P/S ratio
3.92x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$4 – $10
Volume
1.9M
WallStSmart proprietary scores
40
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A5.0
Quality
C+5.0
Profitability
C+5.3
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$11.14
+70.60%
12-Month target
—
—
Intrinsic (DCF)
$7.25
Margin of safety
+4.69%
1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $19.71M — positive
+ Revenue growth 42.80% QoQ
Risks
- Thin margins at 0.19%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $110.25M | $163.91M | $203.07M | $291.85M | $291.85M |
| Net income | $-94.66M | $-62.26M | $-54.84M | $554000.00 | $11.08M |
| EPS | — | — | — | — | $0.00 |
| Free cash flow | $-103.42M | $-49.29M | $-37.85M | $27.93M | $19.71M |
| Profit margin | -85.86% | -37.98% | -27.00% | 0.19% | 0.19% |
Peer comparison
Smart narrative
Xeris Pharmaceuticals Inc trades at $6.53. Our Smart Value Score of 40/100 indicates the stock is fair. TTM revenue stands at $291.85M. with profit margins at 0.19%. Our DCF model estimates intrinsic value at $7.25.
Frequently asked questions
What is Xeris Pharmaceuticals Inc's stock price?
Xeris Pharmaceuticals Inc (XERS) trades at $6.53.
Is Xeris Pharmaceuticals Inc overvalued?
Smart Value Score 40/100 (Grade D, Sell). DCF value $7.25.
What is the price target of Xeris Pharmaceuticals Inc (XERS)?
The analyst target price is $11.14, representing +70.6% upside from the current price of $6.53.
What is the intrinsic value of Xeris Pharmaceuticals Inc (XERS)?
Based on our DCF model, intrinsic value is $7.25, a +4.7% margin of safety versus $6.53.
What is Xeris Pharmaceuticals Inc's revenue?
TTM revenue is $291.85M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.92x
ROE-617.00%
Beta0.92
50D MA$5.92
200D MA$7.08
Shares out0.17B
Float0.16B
Short ratio—
Avg volume1.9M
Performance
1 week+8.44%
1 month+1.68%
3 months-23.06%
YTD-23.06%
1 year—
3 years—
5 years—